BSE filing, NSE: INDOMIM. Summary written from the filing by ALFA Finder's alert engine.
Indo-MIM Ltd: key numbers
- Share price
- ₹1,158.00
- Market cap
- ₹57,261 Cr
- Revenue (annual)
- ₹4,193 Cr
- Net profit (annual)
- ₹533.5 Cr
- Promoter holding
- 77.65%
- FII holding
- 2.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo-MIM Ltd
All →Indo-MIM Merger & Restructuring Worth ₹45 Cr
INDO-MIM's board approved incorporation of a wholly-owned manufacturing subsidiary in Vietnam. The company will invest ₹45 Crore over five years for electronics assembly and export.
- Value
- ₹45.00 Cr
- Execution
- 5 years
Indo-MIM Management Change
INDO-MIM Limited announced the re-appointment of Mrs. Rajni Anil Mishra, Mrs. Meera Shankar, and Mrs. Sujitha Karnad as Non-Executive Independent Directors for a 60-month term.
Indo-MIM Merger & Restructuring
INDO-MIM Ltd re-appointed three Independent Directors, revised its Insider Trading Policy, and approved the incorporation of a wholly-owned subsidiary in Vietnam.
Indo-MIM Other Announcement
INDO-MIM Ltd updated its CIN from U to L and listed status from No to Yes on MCA records following its July 2026 listing. No change to share capital, management, or operations.
Indo-MIM Price Movement Clarification
INDO-MIM clarified that its recent stock price movement is market-driven. The company confirmed all material disclosures under Reg 30 have been made.
Indo-MIM Annual General Meeting
INDO-MIM held its 30th AGM via video conference on September 22, 2026. Routine resolutions were adopted including financial statements and ESOP plan modifications.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.